- US11679107utility2023Certain Aryl Pladienolide Compounds and Methods of Use0 cites
- US11660275utility2023Epilepsy Treatment Agent0 cites
- US11642347utility2023EZH2 Inhibitors for Treating Lymphoma0 cites
- USD0980431design2023Component for a Health Condition Monitoring System0 cites
- US11572414utility2023Eribulin Antibody-drug Conjugates and Methods of Use0 cites
- US11547705utility2023Combination of a PD-1 Antagonist and a VEGF-R/FGFR/RET Tyrosine Kinase Inhibitor for Treating Cancer0 cites
- US11547743utility2023Lyophilized Formulation of HGF0 cites
- US11548898utility2023Synthesis of Halichondrins0 cites
- US11548926utility2023Method for Producing an Active Hepatocyte Growth Factor (HGF)0 cites
- US11542269utility2023Prins Reaction and Compounds Useful in the Synthesis of Halichondrin Macrolides and Analogs Thereof0 cites
← PreviousPage 3 of 3